Skip to main content

Table 3 Solutions for the cancer vs human problem

From: Predicting and characterizing selective multiple drug treatments for metabolicdiseases and cancer

#

Drugs

Side effect

1

Floxuridine (# 20)

1

2

Mycophenolic acid (# 42)

4

3

Trimethoprim (# 29)

5

4

Methotrexate (# 11)

5

5

Atovaquone (# 69)

6

6

Tyloxapol (# 85)

6

7

Ezetimibe (# 56)

12

8

Pemetrexed (# 41)

15

9

Ribavirin (# 51)

17

10

Quinacrine (# 36)

22

11

Myo-Inositol (# 82)

29

12

Tioconazole (# 60)

34

13

Naftifine (# 43)

34

14

Simvastatin (# 4)

42

15

Leflunomide (# 66)

42

16

Auranofin (# 59) - Fomepizole (# 75)

47

17

Indomethacin (# 22)

48

18

Diclofenac (# 35)

55

19

Hydroxyurea (# 16)

56

20

Arsenic trioxide (# 72)

56

21

Gemcitabine (# 30)

99

  1. We report the solutions and the side effects σ(D) forthe inhibition with approved drugs. Drug numbers refer to Additional file1: Table S1. Bold font indicates that thesolution has an experimental validation.